|
|
| | 1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine Basic information |
| Product Name: | 1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine | | Synonyms: | AURORA KA-7672;4-iodo-2,5-dimethoxyphenylisopropylamine;4-Iodo-2,5-dimethoxyphenylisopropylamine hydrochloride, (+-)-isomer;4-Iodo-2,5-dimethoxyphenylisopropylamine hydrochloride, (R)-isomer;2,5-DiMethoxy-4-iodoMethaMphetaMine;4-Iodo-2,5-dieMthoxyaMphetaMine;4-Iodo-2,5-diMethoxy-α-MethylbenzeneethanaMine;2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine | | CAS: | 64584-34-5 | | MF: | C11H16INO2 | | MW: | 321.16 | | EINECS: | | | Product Categories: | Amines;Aromatics;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals | | Mol File: | 64584-34-5.mol |  |
| | 1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine Chemical Properties |
| Boiling point | 361.5±42.0 °C(Predicted) | | density | 1.508±0.06 g/cm3(Predicted) | | pka | 9.46±0.10(Predicted) |
| | 1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine Usage And Synthesis |
| Uses | 2,5-Dimethoxy-4-iodoamphetamine (DOI) is a psychedelic drug and a substituted amphetamine of the phenethylamine family. It is also a powerful anti-inflammatory that is effective at doses on the order of 100 micrograms in humans, far below its effective dose as a psychedelic. Despite being a substituted amphetamine, it is not a stimulant. DOI has a stereocenter and R-(-)-DOI is the more active stereoisomer. DOI is a 5-HT2A, 5-HT2B, and 5-HT2C receptor partial agonist. Its psychedelic effects are mediated by its agonistic properties at the 5-HT2A receptor.
This is a controlled substance. | | Definition | ChEBI: An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4. |
| | 1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine Preparation Products And Raw materials |
|